Ultime notizie per Bank of Montreal (NYSE:BMO) Azioni

Bank of Montreal

Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, US P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.

Bank of Montreal FXDFR PRF PERPETUAL CAD 25 - Ser 46 Cls B NVCC

Binamon

Blue Moon Metals Inc

BLUE MOON METALS INC by BLUE MOON METALS INC.

News

Reported Earlier, BMO Secures C$875M After Court Overturns Petters Ponzi Scheme Judgment

Shares of Bank of Montreal (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bmo#NYSE">BMO</a>) declined 6.2% on the NYSE in response to weak third-quarter fiscal 2024 (ended July 31) results. Adjusted earnings per share of C$2.64 declined 10.2% year over year.
A significant jump in provision for credit losses and lower net interest income (NII) primarily hurt the results. However, an increase in non-interest income, higher loans and deposit balance and lower expenses acted as a tailwind.
After considering non-recurring items, net income was C$1.87 billion ($1.37 billion), which grew 19.2% from the year-ago quarter.
<h2>BMO&#39;s Revenues Rise, Expenses Dip</h2>
Total revenues (on an adjusted basis), net of insurance claims, commissions and changes in policy benefit liabilities (CCPB), were C$8.21 billion ($5.99 billion), up marginally year over year.
NII declined 2% year over year to C$4.81 billion ($3.51 billion). On the other hand, non-interest income came in at C$3.4 billion ($2.48 billion), up 3.4%.
Adjusted non-interest expenses decreased 5% to C$4.7 billion ($3.43 billion).
The adjusted efficiency ratio (net of CCPB) was 57.3%, down from 60.3% as of July 31, 2023.
Provision for credit losses (adjusted) was C$906 million ($515.5 million) in the reported quarter, surging 84.1% from the year-ago quarter.
<h2>Loans &amp; Deposits Rise for Bank of Montreal</h2>
As of July 31, 2024, total assets were C$1.4 trillion ($1 trillion), up 1.9% from the prior quarter end.
Bank of Montreal&#39;s total net loans grew 2.5% sequentially to C$673.2 billion ($486.9 billion). Total deposits increased 3% to C$965.2 billion ($698.1 billion).
<h2>BMO&#39;s Profitability Ratios Decline, Capital Ratios Improve</h2>
Bank of Montreal&#39;s return on common equity (as adjusted) was 10.6% in the fiscal third quarter compared with 12.5% on July 31, 2023. Adjusted return on tangible common equity was 14.2% compared with 17.1% in the year-ago quarter.
As of July 31, 2024, the Common Equity Tier-I ratio was 13%, up from 12.3% a year ago. The Tier-I capital ratio was 14.8% compared with the previous year&#39;s 14%.
<h2>Our Take on BMO</h2>
Bank of Montreal&#39;s focus and efforts align with its organic and business restructuring strategies and are anticipated to support revenues in the upcoming period. However, elevated expenses and an uncertain macroeconomic backdrop are headwinds.
<div class="chart_embed">
<h3>Bank Of Montreal Price, Consensus and EPS Surprise</h3>
<img alt="Bank Of Montreal Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/59/1724849830.png" style="height:265px; width:584px" title="" />
Bank Of Montreal price-consensus-eps-surprise-chart | Bank Of Montreal Quote
Currently, BMO carries a Zacks Rank #4 (Sell).
</div>
<h2>Performance &amp; Earnings Date Other Canadian Banks</h2>
Toronto-Dominion Bank (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/td#NYSE">TD</a>) incurred a loss on a GAAP basis in the third quarter of fiscal 2024 (ended July 31). The quarterly loss was primarily due to provisions for the penalties related to investigations concerning its anti-money laundering practices by the U.S. regulators.
Net loss (GAAP basis) was C$181 million ($132.2 million) against net income of $2.88 billion in the prior-year quarter.
Huge increases in provisions for credit losses and higher expenses acted as undermining factors. On the other hand, growth in NII and non-interest income and higher loan balance offered much-needed support to TD&#39;s quarterly performance.
Canadian Imperial Bank of Commerce (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cm#NYSE">CM</a>) is slated to announce quarterly numbers on Aug. 29.
Over the past seven days, the Zacks Consensus Estimate for CM&#39;s quarterly earnings has been revised marginally lower.
<a href="https://www.zacks.com/stock/news/2328317/bank-of-montreal-stock-tanks-6-2-as-high-provisions-hurt-q3-earnings?cid=CS-BENZ-FT-analyst_blog|earnings_article-2328317">To read this article on Zacks.com click here.</a>

Earnings

Large Cap

Markets

Analyst Ratings

Trading Ideas

Bank of Montreal Stock Tanks 6.2% as High Provisions Hurt Q3 Earnings

TD Securities analyst Mario Mendonca downgrades Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) from Buy to Hold and lowers the price target from C$130 to C$114.

Downgrades

Price Target

TSX:BMO

TD Securities Downgrades Bank of Montreal to Hold, Lowers Price Target to C$114

Barclays analyst Brian Morton maintains Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) with a Overweight and lowers the price target from C$132 to C$126.

Barclays Maintains Overweight on Bank of Montreal, Lowers Price Target to C$126

Scotiabank analyst Meny Grauman downgrades Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) from Sector Outperform to Sector Perform and lowers the price target from C$123 to C$112.

Scotiabank Downgrades Bank of Montreal to Sector Perform, Lowers Price Target to C$112

RBC Capital analyst Darko Mihelic maintains Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) with a Sector Perform and lowers the price target from C$118 to C$106.

RBC Capital Maintains Sector Perform on Bank of Montreal, Lowers Price Target to C$106

B of A Securities analyst Ebrahim Poonawala downgrades Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) from Buy to Neutral and lowers the price target from $134 to $117.

B of A Securities Downgrades Bank of Montreal to Neutral, Lowers Price Target to $117

Financial giants have made a conspicuous bullish move on Bank of Montreal. Our analysis of options history for Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) revealed 8 unusual trades.
Delving into the details, we found 37% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $199,002, and 4 were calls, valued at $159,180.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $70.0 and $90.0 for Bank of Montreal, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Bank of Montreal options trades today is 524.83 with a total volume of 1,929.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Bank of Montreal's big money trades within a strike price range of $70.0 to $90.0 over the last 30 days.
<h3>Bank of Montreal Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724779861_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BMO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$2.5</td>
<td>$2.25</td>
<td>$2.5</td>
<td>$85.00</td>
<td>$100.0K</td>
<td>434</td>
<td>400</td>
</tr>
<tr>
<td>BMO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.5</td>
<td>$6.3</td>
<td>$6.44</td>
<td>$80.00</td>
<td>$61.1K</td>
<td>49</td>
<td>95</td>
</tr>
<tr>
<td>BMO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$2.0</td>
<td>$1.9</td>
<td>$1.9</td>
<td>$85.00</td>
<td>$47.5K</td>
<td>1.6K</td>
<td>1.0K</td>
</tr>
<tr>
<td>BMO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$14.9</td>
<td>$14.6</td>
<td>$14.7</td>
<td>$70.00</td>
<td>$36.7K</td>
<td>108</td>
<td>35</td>
</tr>
<tr>
<td>BMO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$3.3</td>
<td>$3.1</td>
<td>$3.2</td>
<td>$85.00</td>
<td>$32.0K</td>
<td>468</td>
<td>117</td>
</tr>
</tbody>
</table>

<h3>About Bank of Montreal</h3>
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, US P&amp;C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
<h3>Bank of Montreal's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,697,534, with BMO's price down by -6.83%, positioned at $82.71.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bank of Montreal with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

A Closer Look at Bank of Montreal's Options Market Dynamics

WIIM

Bank of Montreal shares are trading lower after the company reported worse-than-expected Q3 financial results.

Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) reported quarterly earnings of $1.93 per share which missed the analyst consensus estimate of $2.77 by 30.32 percent. The company reported quarterly sales of $5.98 billion which missed the analyst consensus estimate of $8.21 billion by 27.17 percent. This is a 1.31 percent increase over sales of $5.90 billion the same period last year.

Earnings Misses

Bank of Montreal Q3 2024 Adj EPS $1.93 Misses $2.04 Estimate, Sales $5.98B Miss $6.05B Estimate

CADE

CVBF

EWBC

FCNCA

FMAO

GGAL

HBAN

IBTX

INDB

PPBI

TCBI

WSFS

WTFC

Shares of banking companies are trading lower amid overall market weakness on US economic concerns.

BBAR

FITB

HMNF

HSBC

MUFG

VBFC

Shares of banking companies are trading lower amid overall market weakness following weak US jobs data.

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said Vertiv Holdings Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) is &#8220;very good,&#8221; however: &#8220;I do prefer, because it was down today, that you <a href="https://www.benzinga.com/news/large-cap/24/07/40001668/ford-stellantis-and-dell-are-among-top-12-large-cap-losers-last-week-july-21-july-27-are-the-other">buy the stock of Dover (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>).&#8221;</a>
When asked about Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>), he said, &#8220;There's a gigantic secondary coming on, a lot of insider stock going, and I don't like that. I don't like to see that, because the company's losing a lot of money. So, I don't want to be there.&#8221;
The &#8220;Mad Money&#8221; host recommended buying Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) right here.
&#8220;I got to get to the bottom of Celsius (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>). I mean, this thing has fallen — it looks like a two-for-one split,&#8221; he said.
Celsius will release its second quarter financial results before the opening bell on Tuesday, Aug. 6.
Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) is a buy, he said.
When asked about Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>), Cramer said he likes Royal Caribbean (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) and Viking Holdings Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>) more.
&#8220;I think Hanneke's [CEO of Logitech] doing a really job,&#8221; Cramer said when asked about Logitech International S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>). &#8220;It could be a Christmas play, not so much now.&#8221;
Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) is &#8220;one of the winners of the year. I think it's going to continue to win,&#8221; Cramer said.
Price Action:
<ul>
<li>Vertiv shares gained 7.8% to settle at $78.70 on Wednesday.</li>
<li>Serve Robotics shares gained 16.8% to close at $17.52.</li>
<li>Vistra shares jumped 14.8% to close at $79.22.</li>
<li>Bank of Montreal shares gained 2.2% to settle at $84.33.</li>
<li>Celsius shares rose 1.1% to close at $46.83 on Wednesday.</li>
<li>AMD shares gained 4.4% to settle at $144.48 on Wednesday.</li>
<li>Carnival shares rose 0.5% to settle at $35.70 during Wednesday's session.</li>
<li>Logitech shares gained 1.9% to close at $90.57.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/07/40067769/wall-streets-most-accurate-analysts-weigh-in-on-3-industrials-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 4% Dividend Yields</a></li>
</ul>

Long Ideas

Media

CELH

LOGI

SERV

Jim Cramer Says This Utilities Stock 'Will Continue To Win,' Recommends Buying AMD

Bank Of Montreal shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform.

RBC Capital analyst Darko Mihelic downgrades Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) from Outperform to Sector Perform and lowers the price target from C$124 to C$118.

RBC Capital Downgrades Bank of Montreal to Sector Perform, Lowers Price Target to C$118

Macro Economic Events

Economics

Federal Reserve

Fed Bank Stress Test Results: BMO, Citizens Financial And HSBC Saw Lowest Capital Ratios Under Stress Test; Banks Permitted To Report Capital Plans To Investors Beginning Friday Afternoon After Us Market Close

Keefe, Bruyette &amp; Woods analyst Mike Rizvanovic downgrades Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) from Outperform to Market Perform and lowers the price target from $137 to $124.

Keefe, Bruyette & Woods Downgrades Bank of Montreal to Market Perform, Lowers Price Target to $124

Shares of Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) fell sharply during Wednesday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/BMO/earnings">second-quarter financial results</a>.
Bank of Montreal posted quarterly adjusted earnings of C$2.59 per share, missing market estimates of C$2.77 per share. The company's quarterly sales came in at C$7.988 billion missing expectations of C$8.046 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Bank of Montreal shares declined 7.1% to $89.32 on Wednesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>ReShape Lifesciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) shares jumped 82.8% to $0.3799 a day after it received the nod from the U.S. Patent And Trademark Office to issue a patent for its obesity treatment.</li>
<li>Innovative Eyewear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) shares jumped 56.1% to $0.64 after the company launched its Eddie Bauer Smart Eyewear collection.</li>
<li>Brand Engagement Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) climbed 41% to $1.7900 after the company announced a $4.95 million private placement and appointed Paul Chang to co-CEO.</li>
<li>Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) gained 40% to $2.10. The company yesterday announced that it received an order from the City of Lancaster Public Utilities Department for its SD7 Push-to-Talk handsets, VK7 Vehicle Kits and related accessories.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) climbed 29% to $6.88 after the company announced a partnership with Verizon for direct-to-cellular AST SpaceMobile service when needed for Verizon customers.</li>
<li>Cheche Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCG#NASDAQ">CCG</a>) shares gained 25.4% to $1.67. Cheche Group is expected to host a conference call to discuss first quarter 2024 results on Thursday, May 30.</li>
<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) gained 25% to $0.2370.</li>
<li>Globavend Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) jumped 23.5% to $1.89 after the company announced an MOU to acquire Top Logistics.</li>
<li>Ikena Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKNA#NASDAQ">IKNA</a>) gained 22.5% to $1.63 after the company announced it will discontinue development of IK-930 and evaluate strategic options for both the Company and its development pipeline.</li>
<li>Ooma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OOMA#NYSE">OOMA</a>) rose 22.3% to $9.66 after the company reported better-than-expected first-quarter financial results and issued strong guidance for the second quarter.</li>
<li>Tantech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TANH#NASDAQ">TANH</a>) jumped 22% to $0.80. Tantech recently received a notice of non-compliance from the Nasdaq.</li>
<li>Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) rose 21.5% to $20.54 following better-than-expected first-quarter earnings.</li>
<li>SOPHiA GENETICS SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPH#NASDAQ">SOPH</a>) gained 21.1% to $5.96.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) climbed 21% to $0.2290.</li>
<li>Surmodics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRDX#NASDAQ">SRDX</a>) gained 20.3% to $42.23 after the company announced it will be acquired by GTCR for $43 per share in cash for a total equity valuation of roughly $627 million.</li>
<li>Abercrombie &amp; Fitch Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) gained 15.9% to $176.57 following better-than-expected first-quarter financial results.</li>
<li>DICK&#8217;S Sporting Goods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) rose 15.8% to $225.87 as the company reported better-than-expected first-quarter FY24 earnings and raised the outlook.</li>
<li>Semler Scientific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) rose 14.8% to $33.28. The company recently announced that its board of directors adopted bitcoin as its primary treasury reserve asset.</li>
<li>Scorpius Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NYSE">SCPX</a>) shares gained 14.2% to $0.1279 after gaining 6% on Tuesday.</li>
<li>Banzai International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) gained 13.5% to $0.1989. Banzai, last week, announced the pricing of a $2.5 million public offering.</li>
<li>Neonode Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEON#NASDAQ">NEON</a>) jumped 12.9% to $3.2746.</li>
<li>Gyre Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GYRE#NASDAQ">GYRE</a>) jumped 12.3% to $11.40. Gyre Therapeutics announced expected addition to the Russell 2000&#xAE; and Russell 3000&#xAE; Indexes.</li>
<li>Immunovant, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMVT#NASDAQ">IMVT</a>) rose 11.3% to $31.66.</li>
<li>Ascent Solar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) gained 11.2% to $0.1660 following a 3% decline on Tuesday.</li>
<li>Box, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) rose 9.1% to $27.30 as the company reported its first-quarter financial results.</li>
<li>Titan Machinery Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TITN#NASDAQ">TITN</a>) gained 8.2% to $19.18.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Faraday Future Intelligent Electric Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) fell 38.8% to $0.7232. Faraday Future's annual report for fiscal year 2023 showed a revenue of $0.8 million, significantly below analyst estimates of $2.59 million. While the net loss narrowed from $602 million in 2022 to $432 million in 2023, it still paints a concerning financial picture.</li>
<li>AERWINS Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWIN#NASDAQ">AWIN</a>) shares fell 37% to $5.74. AERWINS Technologies shares jumped 143% on Tuesday after the company reported a year-over-year increase in first-quarter EPS results.</li>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares fell 32% to $0.2889 after jumping 84% on Monday.</li>
<li>Cue Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLTH#NASDAQ">HLTH</a>) shares dipped 29.1% to $0.0643 after the company announced that it filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business.</li>
<li>Sharps Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares declined 26.4% to $0.3810 after surging 141% on Tuesday. In an exchange filing, the company said it has entered into a series of agreements with Nephron SC and Nephron Sterile Compounding Centers.</li>
<li>Fangdd Network Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) fell 23.8% to $0.8073.</li>
<li>Genetic Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENE#NASDAQ">GENE</a>) declined 18.4% to $1.7301. GTG launched revolutionary geneType test covering 100% risk of breast and ovarian cancer.</li>
<li>CN Energy Group. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNEY#NASDAQ">CNEY</a>) dipped 18% to $0.51.</li>
<li>Predictive Oncology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) fell 17.6% to $1.72. Predictive Oncology shares surged 31% on Tuesday after the company announced results from its ovarian caner study with UPMC Magee-Womens Hospital.</li>
<li>Maravai LifeSciences Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) dropped 15.3% to $9.15.</li>
<li>American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) shares declined 15.3% to $11.38 after the company announced the departure of its executive vice president and lowered guidance for the second quarter.</li>
<li>Bank OZK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OZK#NASDAQ">OZK</a>) fell 15% to $39.30 after Citigroup downgraded the stock from Buy to Sell and lowered its price target from $57 to $37.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) dipped 15% to $0.0909.</li>
<li>Onfolio Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONFO#NASDAQ">ONFO</a>) shares fell 14.3% to $1.13 in pre-market trading after jumping around 36% on Tuesday. Onfolio Holdings, last week, posted a quarterly loss of 14 cents per share.</li>
<li>Veru Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERU#NASDAQ">VERU</a>) fell 13.1% to $0.9644.</li>
<li>Telephone and Data Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) fell 9.3% to $17.31. JP Morgan analyst Sebastiano Petti maintained Telephone and Data with an Overweight and lowered the price target from $36 to $34.</li>
<li>Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) fell 6.4% to $23.81.</li>
<li>Advance Auto Parts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) fell 5.5% to $66.28 following quarterly earnings.</li>
<li>CAVA Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) shares declined 4.2% to $78.92 following first-quarter results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/39062044/amazon-target-diamondback-energy-and-more-on-cnbcs-final-trades">Amazon, Target, Diamondback Energy And More On CNBC&#8217;s &#8216;Final Trades</a>&#8216;

Intraday Update

Movers

ASTI

ASTS

AWIN

BNAI

BNZI

CAVA

CHWY

CNEY

CRKN

FFIE

GENE

GYRE

HLTH

IKNA

IMVT

Kintara Therapeutics, Inc. - Common Stock

KTRA

LUCY

MBIO

MRVI

NEON

ONFO

OOMA

POAI

RSLS

SCPX

SMLR

SOBR

SOPH

SRDX

STSS

SYTA

TANH

TITN

TOST

VERU

Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Bank of Montreal shares are trading lower after the company reported worse-than-expected Q2 financial results.

&nbsp;Bank of&nbsp;Montreal&nbsp;(TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) today announced at its Board of Directors declared a quarterly dividend of&nbsp;$1.55&nbsp;per share on paid-up common shares of Bank of&nbsp;Montreal&nbsp;for the&nbsp;third quarter&nbsp;of fiscal year 2024 (&quot;Q3&nbsp;2024 Dividend&quot;), a&nbsp;4 cent, or 3 per cent, increase from the prior quarter, up 5 per cent from the prior year.

Dividends

Bank Of Montreal Increases Quarterly Dividend To C$1.55/Share From C$1.51, Payable August 27, 2024

What Canadian Bank Earnings Say About The Health Of The Financial Sector

TD: It's All In The Long Game

My Dividend Stock Portfolio: New August Dividend Record - 101 Holdings With 17 Buys

DFP: The Portfolio Is Not Keeping Up With The Share Price Of This CEF

Bank Of Montreal (TSE:BMO) has released an update. The Bank of Montreal has announced it will redeem all outstanding Non-Cumulative 5-Year Rate Res...

Bank of Montreal Redeems Series 31 Shares

ClearBridge Canadian Equity Strategy Q3 2024 Commentary

Diversified Royalty: A Look At The Valuation On This 8% Yielder

My Dividend Stock Portfolio: New September Dividend Record - 100 Holdings With 12 Buys

Comments

Bank of Montreal

Notizie

Ultime notizie per Bank of Montreal (NYSE:BMO) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO